Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
TAIPEI, Taiwan, February 21, 2…
Shanghai Concord Medical Cancer Center’s Basic Medical Services have been Fully Covered by Medical Insurance
BEIJING, Feb. 20, 2019 /PRNews…
Future of Clinical Laboratories: How to Adapt Your Strategy to the Declining Reimbursements and Be Successful
Transformational Health expert…
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
– Proxy-CRISPR technolog…
AGC Biologics A/S and Calypso Biotech BV Announce Agreement for Process Development and cGMP Manufacture of CALY-002
COPENHAGEN, Denmark and AMSTER…
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results
-Earnings Call Scheduled for 8…
Berry Genomics and Prenetics Announce Key Management Hires for Consumer Genetics Testing Platform
New Company to be called ̶…
